JNCE

Jounce Therapeutics, Inc.

Healthcare

Set alert

Price alert · JNCE

All alert types
1.88 0.00 0.00%
As of May 3, 2023
1.88 Day range 1.93

52-week range unavailable

Open
1.92
Prev close
1.88
Mkt cap
101.59M
Vol
11.60M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.88
High
1.93
Forward P/E
-1.83
Beta
0.75
Short ratio
0.48
Inst. own
85.33%
Dividend
0.00
Ex-div date
Earnings
May 4, 2023
50-d avg
1.64
200-d avg
1.93
1y target
2.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for JNCE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2014: -35.9×FY 2015: -11.2×FY 2016: -38.3×FY 2017: -23.2×FY 2018: -4.0×FY 2019: 5.1×FY 2020: -5.6×FY 2021: -4.6×FY 2022: -1.1×
FY 2014 5y median -4.0× FY 2022
P/S 0.7×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 14.0×FY 2017: 5.3×FY 2018: 1.7×FY 2019: 2.0×FY 2020: 4.0×FY 2021: 15.5×FY 2022: 0.7×
FY 2014 5y median 2.0× FY 2022
P/B 0.3×
FY 2014: -712×FY 2015: 7.1×FY 2016: 7.2×FY 2017: 2.3×FY 2018: 1.1×FY 2019: 1.7×FY 2020: 1.2×FY 2021: 1.9×FY 2022: 0.3×
FY 2014 5y median 1.2× FY 2022
P/FCF -1.9×
FY 2014: -24.4×FY 2015: -11.4×FY 2016: 2.9×FY 2017: -3.6×FY 2018: -1.7×FY 2019: -9.3×FY 2020: -8.9×FY 2021: -5.0×FY 2022: -1.9×
FY 2014 5y median -5.0× FY 2022
EV/EBITDA 1.7×
FY 2014: -40.2×FY 2015: -10.1×FY 2016: -40.4×FY 2017: -30.0×FY 2018: -2.6×FY 2019: 4.8×FY 2020: -2.6×FY 2021: -3.7×FY 2022: 1.7×
FY 2014 5y median -2.6× FY 2022
EV/Sales -1.0×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 12.8×FY 2017: 5.0×FY 2018: 0.9×FY 2019: 1.7×FY 2020: 1.9×FY 2021: 12.5×FY 2022: -1.0×
FY 2014 5y median 1.7× FY 2022
FCF Yield -51.9%
FY 2014: -4.1%FY 2015: -8.7%FY 2016: 34.1%FY 2017: -27.6%FY 2018: -59.2%FY 2019: -10.8%FY 2020: -11.2%FY 2021: -20.1%FY 2022: -51.9%
FY 2014 5y median -20.1% FY 2022

Profitability

Gross Margin 100.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%
FY 2014 5y median 100.0% FY 2022
Operating Margin -63.7%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: -38.9%FY 2017: -26.8%FY 2018: -48.0%FY 2019: 35.7%FY 2020: -72.4%FY 2021: -338.4%FY 2022: -63.7%
FY 2014 5y median -63.7% FY 2022
Net Margin -62.1%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: -36.8%FY 2017: -23.0%FY 2018: -42.0%FY 2019: 38.4%FY 2020: -70.3%FY 2021: -337.7%FY 2022: -62.1%
FY 2014 5y median -62.1% FY 2022
ROE -27.8%
FY 2014: 1965.6%FY 2015: -63.6%FY 2016: -19.1%FY 2017: -9.8%FY 2018: -26.3%FY 2019: 32.5%FY 2020: -20.7%FY 2021: -40.6%FY 2022: -27.8%
FY 2014 5y median -26.3% FY 2022
ROIC -27.0%
FY 2014: -320.8%FY 2015: -65.7%FY 2016: -8.0%FY 2017: -8.2%FY 2018: -21.0%FY 2019: 27.1%FY 2020: -19.8%FY 2021: -38.3%FY 2022: -27.0%
FY 2014 5y median -21.0% FY 2022
ROA -24.0%
FY 2014: -139.9%FY 2015: -53.9%FY 2016: -5.1%FY 2017: -5.5%FY 2018: -12.8%FY 2019: 27.6%FY 2020: -18.0%FY 2021: -36.0%FY 2022: -24.0%
FY 2014 5y median -18.0% FY 2022

Growth (YoY)

Revenue 204.8%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 92.6%FY 2018: -9.0%FY 2019: 126.8%FY 2020: -57.8%FY 2021: -56.8%FY 2022: 204.8%
FY 2014 FY 2022
Operating Income 42.6%
FY 2014: 0.0%FY 2015: -87.5%FY 2016: 52.4%FY 2017: -32.8%FY 2018: -62.9%FY 2019: 268.8%FY 2020: -185.4%FY 2021: -101.8%FY 2022: 42.6%
FY 2014 FY 2022
EPS (diluted) 45.6%
FY 2014: 0.0%FY 2015: -220.8%FY 2016: 70.8%FY 2017: -22.2%FY 2018: -52.7%FY 2019: 297.6%FY 2020: -174.7%FY 2021: -46.8%FY 2022: 45.6%
FY 2014 FY 2022
Free Cash Flow 64.5%
FY 2014: 0.0%FY 2015: -79.0%FY 2016: 735.1%FY 2017: -159.6%FY 2018: 38.6%FY 2019: 52.1%FY 2020: 10.4%FY 2021: -200.8%FY 2022: 64.5%
FY 2014 FY 2022

Financial Health

Current Ratio 8.4×
FY 2014: 1.2×FY 2015: 6.8×FY 2016: 1.7×FY 2017: 4.1×FY 2018: 2.9×FY 2019: 12.1×FY 2020: 10.9×FY 2021: 10.1×FY 2022: 8.4×
FY 2014 5y median 10.1× FY 2022
Quick Ratio 8.4×
FY 2014: 1.2×FY 2015: 6.8×FY 2016: 1.7×FY 2017: 4.1×FY 2018: 2.9×FY 2019: 12.1×FY 2020: 10.9×FY 2021: 10.1×FY 2022: 8.4×
FY 2014 5y median 10.1× FY 2022
Debt / Equity 0.1×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×
FY 2014 5y median 0.1× FY 2022
Net Debt / EBITDA 2.8×
FY 2014: 0.2×FY 2015: 1.7×FY 2016: 3.8×FY 2017: 2.0×FY 2018: 2.0×FY 2019: -0.6×FY 2020: 2.9×FY 2021: 0.9×FY 2022: 2.8×
FY 2014 5y median 2.0× FY 2022
Interest Coverage 0.0×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2014 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2014 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2014 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31